Maxele Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Buy
+1,120
New +$415K 0.33% 61
2025
Q4
$375K Sell
1,136
-30
-3% -$10.2K 0.3% 67
2025
Q3
$403K Sell
1,166
-460
-28% -$139K 0.35% 63
2025
Q2
$507K Sell
1,626
-267
-14% -$102K 0.44% 52
2025
Q1
$991K Sell
1,893
-11
-0.6% -$5.62K 0.96% 35
2024
Q4
$963K Buy
+1,904
New +$1.08M 0.92% 37
2022
Q3
$997K Sell
1,974
-5
-0.3% -$2.63K 1.67% 16
2022
Q2
$1.02M Sell
1,979
-52
-3% -$26.1K 1.6% 17
2022
Q1
$1.04M Sell
2,031
-95
-4% -$45.8K 1.29% 25
2021
Q4
$1.07M Buy
+2,126
New +$962K 1.23% 24

Other funds holding UNH

Maxele Advisors's UNH Position: Q2 2026 in Review

Maxele Advisors opened a new position in UnitedHealth (UNH) in Q2 2026: 1,120 shares worth $466K. The stake represents 0.33% of the portfolio and ranks #61 among its holdings. This is a return to the name: Maxele Advisors previously reported a position in UNH as recently as Q4 2025.

Maxele Advisors first reported a position in UNH in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.07M in Q4 2021. 3,373 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Maxele Advisors held 1,120 shares of UnitedHealth worth $466K as of Q2 2026.
  • UnitedHealth was a new Maxele Advisors position in Q2 2026.
  • UnitedHealth made up 0.33% of Maxele Advisors's portfolio in Q2 2026, its #61 holding.
  • Maxele Advisors first reported a position in UnitedHealth in Q4 2021 and has held it in 10 quarters since.
  • Maxele Advisors's UnitedHealth position peaked at $1.07M in Q4 2021.
  • 3,373 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Maxele Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.